HRS-7535, an oral small-molecule GLP-1 receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial

Journal:

Nature Communications

Published:

2026-06-22

DOI:

10.1038/s41467-026-73018-y

Affiliations:

6

Authors:

10

Go to article

Institutions	Authors	Share
Hengrui, China	4.000000	0.40
The People's Liberation Army General Hospital (PLAGH), China	2.000000	0.20
The Second Hospital of Hebei Medical University, China	1.000000	0.10
Zhongda Hospital, SEU, China	1.000000	0.10
Chengdu Second People's Hospital (CDSPH), China	1.000000	0.10
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.10